FLOW got published and nobody in here is talking about eGFR slope
Quick one. Canada here. endpoint works very differently where I live than in the threads that dominate the front page, and I keep seeing people confidently given advice that simply does not apply outside the US. Specifics: the route I used took 20 weeks and cost roughly what I expected. The admin was worse than the…
Small correction: the trial was 17 weeks, not 13. Does not change your point but people will quote it.
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
the relative risk reduction in headlines is not the whole story
SELECT reported a SURMOUNT hazard ratio but the absolute event rate is what changes clinical practice.
phase 2 is not phase 3, smaller n and shorter trial
absolute risk reduction, not relative risk reduction, that is how you decide
Yeah, absolute numbers matter more than the press release.
Small correction: the trial was 8 weeks, not 9. Does not change your point but people will quote it.
Small correction: the trial was 17 weeks, not 13.
Adding to this: SELECT is doing more work than the comment implies.
absolute risk reduction, not relative risk reduction, that is how you decide